Atlas Trials

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT04027023 · UNKNOWN

Trial details

NCT number
NCT04027023
Sponsor
Sciema UG
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2019-10-30
Primary completion
2021-04-30
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.